Meet Our Warriors
Onwujekwu Ozioma
Founder & CEO
Doris Ndah
Project Manager
Ibinabo Tamunotonye
Welfare Manager
Onwujekwu Ogochukwu
Secretary
Bela Asuquo
Member
Tamunotonye Tari Roselyn
Social media manager
WHY CHOOSE US
United in Purpose, Driven by Compassion
In every warrior's heart lies the power to overcome. At Warrior Ozioma Program, we ignite that power, one soul at a time.
How can I support a loved one diagnosed with sickle cell disease?
Supporting a loved one with sickle cell disease starts with understanding their needs and offering empathy and compassion. You can provide practical assistance with daily tasks, accompany them to medical appointments, and lend a listening ear when they need to talk. Additionally, educating yourself about the condition and advocating for their needs within healthcare settings can make a significant difference in their care journey.
What resources does the Warrior Ozioma Program offer for caregivers of sickle cell patients?
Caregivers play a vital role in supporting individuals with sickle cell disease. The Warrior Ozioma Program offers resources and support tailored to caregivers, including informational materials, caregiver support groups, and access to counseling services. We also provide guidance on navigating the healthcare system, managing caregiver stress, and fostering self-care practices to ensure caregivers receive the support they need to fulfill their role effectively.
How does the Warrior Ozioma Program address the mental health challenges associated with sickle cell disease?
Mental health is an essential aspect of overall well-being for individuals living with sickle cell disease. The Warrior Ozioma Program recognizes the emotional toll that the condition can take and offers support services to address mental health challenges. This includes access to mental health professionals, peer support groups, and counseling services tailored to the unique needs of sickle cell patients. By prioritizing mental health support, we aim to enhance the overall quality of life for individuals affected by sickle cell disease.
